Rapid fish health assessment for the aquaculture industry

WellFish is an aquaculture-diagnostics start-up currently offering rapid fish health assessment for the aquaculture industry through blood-based clinical chemistry analysis. The diagnostics technology uses blood biomarkers and artificial intelligence to determine the health status of fish, enabling fish farmers to monitor and improve the health and welfare of their fish stocks to optimise production.

Founders

  • Professor Brian Quinn

Founders

  • Professor Brian Quinn
Dive Deeper

WellFish is an aquaculture-diagnostics early stage company currently offering rapid fish health assessment for the aquaculture industry through blood-based clinical chemistry analysis.

Spun out of the University of the west of Scotland in 2021, WellFish had its first commercial monitoring and diagnostic sales later that year.

The diagnostics technology uses blood biomarkers and artificial intelligence to determine the health status of fish, enabling fish farmers to monitor and improve the health and welfare of their fish stocks, while optimising production. Aquaculture diagnostics is a £3 billion and growing market, with value creation potential through optimizing feed and drug sales through data insights. The UK-based company, which is headquartered in Paisley, Scotland and has operations in UK, Canada and Norway, plans to offer feed optimisation and aquaculture healthcare in the future.